| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Werewolf Therapeutics, Inc. | Director | Stock Option (right to buy) | 27,000 | 12 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HOWL | Werewolf Therapeutics, Inc. | 12 Jun 2025 | 1 | $0 | 4 | Director | 13 Jun 2025, 16:10 |
| HOWL | Werewolf Therapeutics, Inc. | 24 May 2024 | 1 | $0 | 4 | Director | 24 May 2024, 19:48 |
| HOWL | Werewolf Therapeutics, Inc. | 04 Jan 2024 | 1 | $0 | 4 | Director | 04 Jan 2024, 19:19 |
| HOWL | Werewolf Therapeutics, Inc. | 04 Jan 2024 | 0 | $0 | 3 | Director | 04 Jan 2024, 19:13 |